The New 3D Printed Left Atrial Appendage Closure with a Novel Holdfast Device: A Pre-Clinical Feasibility Animal Study.

about

Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.

P2860

Q45974877-D1004345-DF96-4364-8FFB-A631BCB33519

P2860

The New 3D Printed Left Atrial Appendage Closure with a Novel Holdfast Device: A Pre-Clinical Feasibility Animal Study.

Item

http://www.wikidata.org/entity/Q36028038

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The New 3D Printed Left Atrial ...... ical Feasibility Animal Study.

@ast

The New 3D Printed Left Atrial ...... ical Feasibility Animal Study.

@en

type

Item

label

The New 3D Printed Left Atrial ...... ical Feasibility Animal Study.

@ast

The New 3D Printed Left Atrial ...... ical Feasibility Animal Study.

@en

prefLabel

The New 3D Printed Left Atrial ...... ical Feasibility Animal Study.

@ast

The New 3D Printed Left Atrial ...... ical Feasibility Animal Study.

@en

P1476

The New 3D Printed Left Atrial ...... ical Feasibility Animal Study.

@en

P2093

D Jagielak

http://www.w3.org/2001/XMLSchema#string

J Rogowski

http://www.w3.org/2001/XMLSchema#string

L Dąbrowski

http://www.w3.org/2001/XMLSchema#string

M Brzeziński

http://www.w3.org/2001/XMLSchema#string

M Pawlak

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of Fatal Bleeding in Episodes of Major Bleeding with New Oral Anticoagulants and Vitamin K Antagonists: A Systematic Review and Meta-Analysis

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial.

Why do patients with atrial fibrillation not receive warfarin?

Left atrial appendage closure to prevent stroke in patients with atrial fibrillation

Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention.

Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.

Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke.

Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

P304

e0154559

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0154559

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27219618

http://www.w3.org/2001/XMLSchema#string

P921

3D printing

P932

4878741

http://www.w3.org/2001/XMLSchema#string

The New 3D Printed Left Atrial Appendage Closure with a Novel Holdfast Device: A Pre-Clinical Feasibility Animal Study.

about

P2860

P2860

The New 3D Printed Left Atrial Appendage Closure with a Novel Holdfast Device: A Pre-Clinical Feasibility Animal Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932